Emerging molecular markers, such as protein expression of CD44, ASCL1, and OTP and TERT gene expression have shown prognostic value in lung NETs, alongside traditional markers like Ki-67 and somatostatin receptors (47–49). The gene discussed is CD44; the disease is lung neuroendocrine neoplasm.